Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

HARMONY BIOSCIENCES HOLDINGS, INC.

(HRMY)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Harmony Biosciences Announces Date of Third Quarter 2021 Financial Results

10/26/2021 | 08:06am EST

PLYMOUTH MEETING, Pa., Oct. 26, 2021 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony" or the "Company") (Nasdaq: HRMY), a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients with rare neurological diseases, today announced that it will issue a press release on the Company's third quarter 2021 financial results on Tuesday, November 9, 2021. Following the release, Harmony will conduct a conference call and live webcast on the same day, at 8:30 a.m. ET.

To participate in the call, please dial (833) 614-1471 (domestic) or +1 (914) 987-7209 (international), and reference passcode 4387084. It is recommended that you dial in at least 10 minutes prior to the call.

The live and replayed webcast of the call will be available on the investor page of our website at https://ir.harmonybiosciences.com/.

A replay of the call will be available within 24 hours by dialing (855) 859-2056 (domestic) or +1 (404) 537-3406 (international) and entering conference ID: 4387084. The replay will be available until November 16, 2021.

About Harmony Biosciences
Harmony Biosciences is a commercial stage pharmaceutical company headquartered in Plymouth Meeting, PA. The Company was established by Paragon Biosciences, LLC, and is focused on providing novel treatment options for people living with rare neurological diseases who have unmet medical needs. For more information on Harmony, please visit the company's website: www.harmonybiosciences.com.

Harmony Biosciences Investor Contact:
Patti Bank
415-513-1284
ir@harmonybiosciences.com 

Harmony Biosciences Media Contact:
Nancy Leone
215-891-6046
nleone@harmonybiosciences.com

Cision
View original content to download multimedia:https://www.prnewswire.com/news-releases/harmony-biosciences-announces-date-of-third-quarter-2021-financial-results-301408119.html

SOURCE Harmony Biosciences


ę PRNewswire 2021
All news about HARMONY BIOSCIENCES HOLDINGS, INC.
12/01Harmony Biosciences to Conduct Phase 3 Trial of Pitolisant for Treatment of Idiopathic ..
MT
12/01Oppenheimer Initiates Harmony Biosciences With Outperform Rating, $55 Price Target
MT
12/01Harmony Biosciences Announces Plans To Initiate Phase 3 Clinical Trial For Treatment Of..
PR
12/01Harmony Biosciences Holdings, Inc. Announces Plans To Initiate Phase 3 Clinical Trial F..
CI
11/22HARMONY BIOSCIENCES : APPOINTS LINDA SZYPER TO ITS BOARD OF DIRECTORS - Form 8-K
PU
11/22HARMONY BIOSCIENCES HOLDINGS, INC. : Change in Directors or Principal Officers, Regulation..
AQ
11/22Harmony Biosciences Appoints Linda Szyper To Its Board Of Directors
PR
11/22Harmony Biosciences Holdings, Inc. Appoints Linda Szyper to Board of Directors
CI
11/18INSIDER SELL : Harmony Biosciences Holdings
MT
11/11Harmony Biosciences To Participate In Two Investor Conferences In November
PR
More news
Analyst Recommendations on HARMONY BIOSCIENCES HOLDINGS, INC.
More recommendations